Abacavir dosing in neonates from birth to 3 months of life: a population pharmacokinetic modelling and simulation study.

Bekker, Adrie; Capparelli, Edmund V; Violari, Avy; Cotton, Mark F; Cababasay, Mae; Wang, Jiajia; Mathiba, Ruth; Wiesner, Lubbe; Wiznia, Andrew; Samson, Pearl; Browning, Renee; Moye, Jack; Nakwa, Firdose L; Decloedt, Eric; Rabie, Helena; Mirochnick, Mark; Cressey, Tim R

Bekker, Adrie; Capparelli, Edmund V; Violari, Avy; Cotton, Mark F; Cababasay, Mae; Wang, Jiajia; Mathiba, Ruth; Wiesner, Lubbe; Wiznia, Andrew; Samson, Pearl; Browning, Renee; Moye, Jack; Nakwa, Firdose L; Decloedt, Eric; Rabie, Helena; Mirochnick, Mark; Cressey, Tim R.

Affiliation

Bekker A; Family Centre for Research with Ubuntu, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa. Electronic address: adrie@sun.ac.za.
Capparelli EV; University of California San Diego, San Diego, CA, USA.
Violari A; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Cotton MF; Family Centre for Research with Ubuntu, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.
Cababasay M; Center for Biostatistics in AIDS Research, Harvard T H Chan School of Public Heath, Boston, MA, USA.
Wang J; Center for Biostatistics in AIDS Research, Harvard T H Chan School of Public Heath, Boston, MA, USA.
Mathiba R; Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa.
Wiesner L; Division of Clinical Pharmacology, University of Cape Town, Cape Town, South Africa.
Wiznia A; Jacobi Medical Center, Bronx, NY, USA.
Samson P; Frontier Science Foundation, Amherst, NY, USA.
Browning R; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
Moye J; Division of Extramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.
Nakwa FL; Department of Paediatrics, University of the Witwatersrand, Johannesburg, South Africa.
Decloedt E; Division of Clinical Pharmacology, Department of Medicine, Stellenbosch University, Cape Town, South Africa.
Rabie H; Family Centre for Research with Ubuntu, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa.
Mirochnick M; Boston University School of Medicine, Boston, MA, USA.
Cressey TR; AMS/PHPT Research Collaboration, Department of Medical Technology, Faculty of Associated Medical Sciences, Chiang Mai University, Chiang Mai, Thailand; MIVEGEC, University of Montpellier, CNRS, IRD, Montpellier, France; Department of Molecular and Clinical Pharmacology, University of Liverpool, Live

Lancet HIV ; 9(1): e24-e31, 2022 01.

Article de En | MEDLINE | ID: mdl-34883066

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Infections à VIH / Agents antiVIH Type d'étude: Guideline / Prognostic_studies Limites: Child / Humans / Infant / Newborn Langue: En Journal: Lancet HIV Année: 2022 Type de document: Article

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google